RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Michael C. Campbell to Schistosomicides

Back to Details
This is a "connection" page, showing publications Michael C. Campbell has written about Schistosomicides.
Michael C. Campbell
Connection Strength
0.294
Schistosomicides
  1. Leas DA, H?berli C, White KL, Shackleford DM, Jones JO, Campbell M, Wu J, Kaushik D, Dong Y, Wallick AI, Charman SA, Keiser J, Davis PH, Vennerstrom JL. Structure-Activity Relationship of Antischistosomal Aryl Hydantoin (AR102). J Med Chem. 2025 Oct 23; 68(20):21725-21738.
    View in: PubMed
    Score: 0.239
  2. Leas DA, Keiser J, Charman SA, Shackleford DM, Jones JO, Campbell M, Chen G, Katneni K, Patil R, Hu M, Pham T, H?berli C, Schulze TT, Neville AJ, Wang X, Dong Y, Davis PH, Vennerstrom JL. Single-Dose Drug Development Candidate for Schistosomiasis. ACS Infect Dis. 2024 11 08; 10(11):3963-3972.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support